CODX - PRICE - Co-Diagnostics, Inc.

Co-Diagnostics, Inc. (CODX) bases its business on the supply of PCR diagnostic systems, which guarantees a stable revenue stream from the sale of consumables. The use of third-party IT capacity for genome sequencing accelerates report delivery. This daily price chart for the stock on the GURU.Markets platform with a value of 1.09 visualizes the asset's dynamics, while sample logistics have been outsourced to external services to minimize operational risks.

Investor interest in the stability of Co-Diagnostics, Inc. (CODX) is reflected in the price 1.09, which aggregates market expectations regarding future cash flows and current business capitalization. By analyzing the price chart, one can assess how the launch of the portable PCR platform and the growth in cartridge sales transform the fundamental value of the shares into real quotes, determining the entry point for capital.